中国生物工程杂志

The early recognition of the primary tumor and targeting agents to tumor are critical to successful treatment. The primary diagnostic cancer and targeting treatment are still not effective enough, because excellent targeting agents are rather scarce. Peptides possess not only appropriate pharmacokinetic properties to serve tumor imaging or therapeutic targeting agents, but also easily deduce peptide residues using phage display technology. Up till present moment, more than 1000 peptides have been identified targeting to tumors, tumor cells, cognate molecules with metastasis and angiogenic vessels.